K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 310.05 INR 1.29% Market Closed
Market Cap: 5B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Relative Value

The Relative Value of one KILITCH stock under the Base Case scenario is 245.88 INR. Compared to the current market price of 310.05 INR, Kilitch Drugs (India) Ltd is Overvalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KILITCH Relative Value
Base Case
245.88 INR
Overvaluation 21%
Relative Value
Price
K
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
32
Median 3Y
2.7
Median 5Y
2.7
Industry
2.5
Forward
2.2
vs History
49
vs Industry
10
Median 3Y
37.2
Median 5Y
39.5
Industry
21.9
Forward
25.5
vs History
vs Industry
1
Median 3Y
11.5
Median 5Y
-17.6
Industry
16.5
vs History
31
vs Industry
3
Median 3Y
180.6
Median 5Y
28.9
Industry
23.6
vs History
20
vs Industry
23
Median 3Y
2
Median 5Y
1.9
Industry
2.1
vs History
26
vs Industry
32
Median 3Y
2.5
Median 5Y
2.4
Industry
2.6
Forward
2
vs History
25
vs Industry
22
Median 3Y
6.6
Median 5Y
6.5
Industry
5.2
vs History
41
vs Industry
15
Median 3Y
21.1
Median 5Y
20.9
Industry
13.3
Forward
12.2
vs History
41
vs Industry
16
Median 3Y
26.2
Median 5Y
26.2
Industry
16.6
Forward
13.7
vs History
vs Industry
1
Median 3Y
9.9
Median 5Y
-16.7
Industry
15.6
vs History
vs Industry
3
Median 3Y
-72.5
Median 5Y
-83.2
Industry
19.1
vs History
20
vs Industry
22
Median 3Y
2.2
Median 5Y
2
Industry
1.9

Multiples Across Competitors

KILITCH Competitors Multiples
Kilitch Drugs (India) Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Kilitch Drugs (India) Ltd
NSE:KILITCH
5B INR 3.3 39.6 23.6 28.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IN
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Average P/E: 33.3
39.6
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top